| Source: |
| Type: |
| Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors. |
| 506- | MF, | doxoR, | Pulsed Electromagnetic Field Stimulation Promotes Anti-cell Proliferative Activity in Doxorubicin-treated Mouse Osteosarcoma Cells |
| - | in-vitro, | OS, | LM8 |
| 512- | MF, | Pulsed Electromagnetic Fields (PEMFs) Trigger Cell Death and Senescence in Cancer Cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | FF95 |
| 515- | MF, | Pulsed Low-Frequency Magnetic Fields Induce Tumor Membrane Disruption and Altered Cell Viability |
| - | in-vitro, | Lung, | A549 |
| 518- | MF, | Moderate and strong static magnetic fields directly affect EGFR kinase domain orientation to inhibit cancer cell proliferation |
| - | in-vitro, | Var, | HCT116 |
| 9267- | MFrot, | EXTH-12. Oncomagnetic Monotherapy Mediated Anti-Tumor Immune Response in Glioblastoma |
| - | Review, | GBM, | NA |
| 227- | MFrot, | MF, | Low Frequency Magnetic Fields Induce Autophagy-associated Cell Death in Lung Cancer through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway |
| - | in-vivo, | Lung, | A549 | - | in-vitro, | Lung, | A549 |
| 226- | MFrot, | MF, | Involvement of midkine expression in the inhibitory effects of low-frequency magnetic fields on cancer cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | NA, | LoVo |
| 220- | MFrot, | MF, | Effect of low frequency magnetic fields on melanoma: tumor inhibition and immune modulation |
| - | in-vitro, | Melanoma, | B16-F10 |
| 516- | MFrot, | immuno, | MF, | Anti-tumor effect of innovative tumor treatment device OM-100 through enhancing anti-PD-1 immunotherapy in glioblastoma growth |
| - | vitro+vivo, | GBM, | U87MG |
| 8461- | Mg, | Effects of Salivary Mg on Head and Neck Carcinoma via TRPM7 |
| - | vitro+vivo, | SCC, | CAL27 | - | in-vitro, | Laryn, | FaDu |
| 9074- | MGF, | Mangiferin prevents the growth of gastric carcinoma by blocking the PI3K-Akt signalling pathway |
| - | in-vitro, | GC, | SGC-7901 | - | in-vitro, | GC, | BGC-823 |
| 9075- | MGF, | Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway |
| - | vitro+vivo, | BC, | MDA-MB-231 |
| 9080- | MGF, | Mangiferin targets PFKFB3 to inhibit glioblastoma progression by suppressing glycolysis and PI3K/AKT/mTOR signaling |
| - | vitro+vivo, | GBM, | NA |
| 9083- | MGF, | Anti-neoplastic effect of mangiferin on human ovarian adenocarcinoma OVCAR8 cells via the regulation of YAP |
| - | vitro+vivo, | Ovarian, | OVCAR8 |
| 9084- | MGF, | Mangiferin blocks proliferation and induces apoptosis of breast cancer cells via suppression of the mevalonate pathway and by proteasome inhibition |
| - | in-vitro, | BC, | NA |
| 9087- | MGF, | Mangiferin in human disease: Multifaceted mechanisms and applications (Review) |
| - | Review, | Var, | NA |
| 9089- | MGF, | Mangiferin targeting HSP90α induces DNA damage in cutaneous squamous cell carcinoma via the ROS/MAPK signaling pathway |
| - | in-vitro, | SCC, | NA |
| 8737- | MGO, | Induction of mitochondrial apoptotic pathway in triple negative breast carcinoma cells by methylglyoxal via generation of reactive oxygen species |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | 4T1 |
| 1776- | MLT, | Therapeutic strategies of melatonin in cancer patients: a systematic review and meta-analysis |
| - | Review, | Var, | NA |
| 1780- | MLT, | Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing |
| - | Review, | Var, | NA |
| 1782- | MLT, | Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities |
| - | Review, | Var, | NA |
| 8669- | MLT, | Melatonin in lung cancer: integrating molecular mechanisms, tumor microenvironment regulation, apoptotic signaling, and therapeutic opportunities |
| - | Review, | Lung, | NA |
| 8663- | MLT, | Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect |
| - | vitro+vivo, | RCC, | 786-O |
| 8662- | MLT, | Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis |
| - | vitro+vivo, | Bladder, | 5637 | - | in-vitro, | CRC, | T24/HTB-9 | - | in-vitro, | HNSCC, | UM-SCC-1 |
| 8684- | MLT, | Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress |
| - | in-vivo, | SCC, | CAL27 | - | in-vivo, | Tong, | SCC9 |
| 8687- | MLT, | Melatonin induces cell cycle arrest and suppresses tumor invasion in urinary bladder urothelial carcinoma |
| - | in-vitro, | CRC, | T24/HTB-9 | - | in-vitro, | Bladder, | UMUC3 |
| 8686- | MLT, | CAP, | Non-thermal plasma-treated melatonin inhibits the biological activity of HCC cells by increasing intracellular ROS levels and reducing RRM2 expression |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Liver, | HUH7 |
| 8683- | MLT, | Intra-tumor ROS amplification by melatonin interferes in the apoptosis-autophagy-inflammation-EMT collusion in the breast tumor microenvironment |
| - | in-vivo, | BC, | NA |
| 8682- | MLT, | Melatonin suppresses tumor proliferation and metastasis by targeting GATA2 in endometrial cancer |
| - | vitro+vivo, | EC, | NA |
| 8680- | MLT, | Function of intramitochondrial melatonin and its association with Warburg metabolism |
| - | Analysis, | Var, | NA |
| 8675- | MLT, | Melatonin combined with antineoplastic drugs or natural products for cancer treatment: An update |
| - | Review, | Var, | NA |
| 5240- | MNPs, | Effect of low frequency magnetic fields on the growth of MNP-treated HT29 colon cancer cells |
| - | in-vitro, | Colon, | HT29 |
| 8615- | MO, | Melissa officinalis Extract Induces Apoptosis and Inhibits Migration in Human Colorectal Cancer Cells |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HT-29 | - | in-vitro, | CRC, | SW-620 |
| 8610- | MO, | Melissa officinalis extract induces apoptosis and inhibits proliferation in colon cancer cells through formation of reactive oxygen species |
| - | in-vitro, | CRC, | HT-29 | - | in-vitro, | Colon, | T84 |
| - | in-vitro, | Melanoma, | A375 | - | in-vitro, | Melanoma, | A2058 |
| 8909- | MO, | Effect of Moringa oleifera on inflammatory diseases: an umbrella review of 26 systematic reviews |
| - | Review, | Nor, | NA |
| 8910- | MO, | Moringa oleifera L. leaf extract induces cell cycle arrest and mitochondrial apoptosis in Dalton's Lymphoma: An in vitro and in vivo study |
| - | vitro+vivo, | lymphoma, | NA |
| 8895- | MOR, | Cisplatin, | Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin |
| - | in-vitro, | Ovarian, | TOV-21G | - | in-vitro, | Ovarian, | SKOV3 |
| 8898- | MOR, | Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells |
| - | in-vitro, | Cerv, | HeLa |
| - | in-vivo, | Bladder, | NA |
| 8868- | MOR, | PacT, | Synergistic effect of morin and paclitaxel impedes cell proliferation through PI3K/AKT/STAT3 signaling axis inhibition in gastric cancer |
| - | in-vitro, | GC, | HGC27 |
| 8863- | MOR, | Morin Inhibits Proliferation of SW480 Colorectal Cancer Cells by Inducing Apoptosis Mediated by Reactive Oxygen Species Formation and Uncoupling of Warburg Effect |
| - | in-vitro, | Colon, | SW48 |
| 8878- | MOR, | Investigating the Effects of Morin and Aminoimidazole Carboxamide Ribonucleotide on the AMPK/mTOR/ULK1 Signaling Pathway in Breast Cancer Cell Line (MCF-7) |
| - | in-vitro, | BC, | MCF7 |
| 8918- | MP, | Cisplatin, | Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling |
| - | in-vitro, | BC, | T47D | - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-231 |
| 8775- | MSM, | Methylsulfonylmethane Induces p53 Independent Apoptosis in HCT-116 Colon Cancer Cells |
| - | Review, | Colon, | HCT116 |
| 8767- | MSM, | Methylsulfonylmethane inhibits HER2 expression through STAT5b in breast cancer cells |
| - | in-vitro, | BC, | NA |
| 8809- | MT/VAE, | Cisplatin, | Synergistic Effects of Mistletoe Lectin and Cisplatin on Triple-Negative Breast Cancer Cells: Insights from 2D and 3D In Vitro Models |
| - | in-vitro, | BC, | MDA-MB-231 |
| 8807- | MT/VAE, | Mistletoe Extracts Inhibit Progressive Growth of Prostate Cancer Cells |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | DU145 | - | in-vitro, | GBM, | LNCaP |
| 8937- | MushCha, | Effects of Inonotus obliquus Polysaccharides on Proliferation, Invasion, Migration, and Apoptosis of Osteosarcoma Cells |
| - | in-vitro, | OS, | MG63 | - | in-vitro, | OS, | U2OS |
| 8939- | MushCha, | Composition of Triterpenoids in Inonotus obliquus and Their Anti-Proliferative Activity on Cancer Cell Lines |
| - | in-vitro, | GC, | AGS | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Pca, | PC3 | - | in-vitro, | CRC, | HT-29 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:327 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid